Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
Background. Cariprazine is a new piperazine derivative atypical antipsychotic, like aripiprazole and brexpiprazole. It has been approved for treating schizophrenia in many countries and has recently been included on the List of Essential Medicines in Russia. Unlike most other atypical antipsychotics...
Main Authors: | Aleksandr M. Reznik, Aleksandr L. Arbuzov, Sergey P. Murin, Aleksey V. Pavlichenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Eco-Vector
2020-10-01
|
Series: | Consortium Psychiatricum |
Subjects: | |
Online Access: | https://www.consortium-psy.com/jour/article/viewFile/40/14 |
Similar Items
-
The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
by: I. Laszlovszky, et al.
Published: (2021-04-01) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
by: Aubel T
Published: (2021-07-01) -
A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
by: Panneer Selvan, et al.
Published: (2024-04-01) -
Using Cariprazine to Ameliorate Negative Symptoms and Metabolic Side Effects of Clozapine and Paliperidone – Clinical Cases
by: Viegas F, et al.
Published: (2022-06-01) -
Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
by: Montes JM, et al.
Published: (2021-02-01)